Authors
Loading...
Prospective study evaluates biomarkers like hepcidin and growth differentiation factor-15 to optimize transfusion in thalassemia patients, suggesting individualized Hb targets may reduce iron overload
Hamdan et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: